A government-backed fund dedicated to ensuring that all citizens, regardless of socioeconomic status, have access to AI-designed cancer therapies. The fund subsidizes drug costs, provides financial assistance for treatment-related expenses, and supports clinical trials in underserved populations. The fund is governed by a council of experts, ethicists, and patient advocates to guarantee fairness and transparency.